DIN 02474522 — TRELEGY ELLIPTA 62.5 MCG; 25 MCG; 100 MCG
TRELEGY ELLIPTA is a powder of Fluticasone Furoate / Umeclidinium / Vilanterol marketed by GLAXOSMITHKLINE INC. The full Fluticasone Furoate / Umeclidinium / Vilanterol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02474522
- Brand name
- TRELEGY ELLIPTA
- Active ingredient
- Fluticasone Furoate / Umeclidinium / Vilanterol
- Strength
- 62.5 MCG; 25 MCG; 100 MCG
- Dosage form
- POWDER
- Route
- INHALATION
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Inhaled corticosteroid (ICS) / long-acting muscarinic antagonist (LAMA) / long-acting beta2-agonist (LABA) triple combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fluticasone Furoate / Umeclidinium / Vilanterol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02515776 | TRELEGY ELLIPTA | 25 MCG; 62.5 MCG; 200 MCG | POWDER | GLAXOSMITHKLINE INC | MARKETED |